论文部分内容阅读
目的探讨针对口腔颌面部血管瘤患者开展聚桂醇注射的临床效果。方法 98例口腔颌面部血管瘤患者,随机分为对照组和治疗组,各49例。对照组患者采用平阳霉素、地塞米松等药物开展基础治疗,治疗组患者在对照组治疗基础上增加聚桂醇注射液。比较两组患者治疗效果及不良反应发生率。结果治疗组患者治疗总有效率为98.0%,不良反应总发生率为6.1%,均明显优于对照组,差异有统计学意义(P<0.05)。结论针对口腔颌面部血管瘤患者开展聚桂醇注射液的治疗,可增加药物治疗效果,提高患者治愈程度,并且有效抑制不良事件的发生。
Objective To investigate the clinical effect of lauromacrogol injection in oral and maxillofacial hemangiomas. Methods A total of 98 patients with oral and maxillofacial hemangiomas were randomly divided into control group and treatment group, with 49 cases in each group. Control group patients with Pingyangmycin, dexamethasone and other drugs to carry out basic treatment, the treatment group patients in the control group based on the increase of La Gui alcohol injection. The treatment effect and incidence of adverse reactions in both groups were compared. Results The total effective rate of the treatment group was 98.0% and the total incidence of adverse reactions was 6.1%, which were significantly better than the control group (P <0.05). Conclusion The treatment of laugenol injection in patients with oral and maxillofacial hemangiomas can increase the therapeutic effect of drugs, improve the degree of cure, and effectively inhibit the occurrence of adverse events.